ContactISSN:e-ISSN: 2578-8965
Author Sign-inReviewer Sign-inRegister
TürkçeEnglish
HomeAim and ScopeAboutGuide for AuthorsSend ArticleLatest IssueArchiveContact Us

Diabetic Retinopathy and Glaucoma Diagnosis with CNN-Based Approach and User Interface for Morphological Analysis of Risky Regions in Fundus Images

Saim Ervural,Emre Ergüler,Mehmet Akif Tokel

  •  Year : 2025
  •  Vol : 5
  •  Issue : 1
  •  Page : 22-44
Early diagnosis and effective monitoring of diabetic retinopathy and glaucoma are essential for preventing vision loss and improving patient outcomes. These conditions, if detected early, can be managed effectively, reducing the burden on healthcare systems and improving quality of life for patients. This study presents the development of a user-friendly software interface designed to assist healthcare professionals in diagnosing these conditions more efficiently. We developed a custom 11-layer Convolutional Neural Network (CNN) architecture, beginning with a rescaling layer and incorporating data augmentation techniques. The primary architecture consists of three convolutional layers containing 16, 32, and 64 filters, respectively, each followed by max pooling layers. A dropout layer with a 0.7 rate was incorporated to reduce the risk of overfitting. The network also features a flattening layer, a dense layer with 128 neurons for feature extraction, and an output layer tailored to the number of classes. For glaucoma detection, a specialized preprocessing step focusing on the optic disc reduced validation loss by approximately 20%. Additionally, a manual zooming feature was developed to enhance diagnostic accuracy in complex glaucoma cases. The algorithms for diabetic retinopathy were meticulously designed to identify and highlight pathological areas, such as edema and hemorrhage. This approach facilitates precise visualization of vascular structures and significantly enhances the model's capability to provide accurate and timely diagnoses. The architecture that emerged upon conclusion of the study demonstrated an accuracy of 98% for diabetic retinopathy and 85% for glaucoma. This study highlights the potential of advanced deep learning combined with practical tools to improve diagnostics, offering clinicians a reliable system to enhance patient outcomes.
Cite this Article As : Ervural, S., Ergüler, E., & Tokel, M. A. (2025). Diabetic Retinopathy and glaucoma diagnosis with CNN-based approach and user ınterface for morphological analysis of risky regions in fundus images. Fivezero, 5(1), 22-44. https://doi.org/10.54486/fivezero.2024.43

Conflict of interest : The authors declare that they have no conflict of interest.

This article is published under the CC BY-NC 4.0 license.
Fivezero Dergisi
2025, Vol5, Issue1
E-ISSN: 2578-8965
Received : , Accepted : , Published Online :

References

  1. [1] American Diabetes Association. (2020). Diagnosis and classification of diabetes mellitus. Diabetes Care, 43(Suppl. 1), S14-S31.
  2. [2] American Diabetes Association. (2020). Standards of Medical Care in Diabetes. Diabetes Care, 43(Suppl. 1), S1-S204.
  3. [3] International Diabetes Federation. (2019). IDF Diabetes Atlas (9th ed.). Brussels, Belgium: Author.
  4. [4] Centers for Disease Control and Prevention. (2021). National Diabetes Statistics Report, 2020. Atlanta, GA: Author.
  5. [5] Hu, F.B. (2011). "Globalization of Diabetes: The Role of Diet, Lifestyle, and Genes". Diabetes Care, 34(6), 1249-1257.
  6. [6] McCarthy, M.I. (2004). "Genetic Contribution to Type 2 Diabetes: Genomic and Epidemiologic Perspectives". American Journal of Epidemiology, 159(12), 1077- 1089.
  7. [7] Huang, E.S. (2011). "The Natural History of Type 2 Diabetes: Validating a Prognostic Model for Diabetes Progression". Diabetes Care, 34(9), 1915-1916.
  8. [8] World Health Organization. (2016). Global report on diabetes. Geneva, Switzerland: Author.
  9. [9] Cheung, N., & Wong, T. Y. (2016). Diabetic retinopathy and systemic vascular complications. Progress in Retinal and Eye Research, 48, 8-39.
  10. [10] Antonetti, D. A., Barber, A. J., Bronson, S. K., Freeman, W. M., Gardner, T. W., Jefferson, L. S., ... & Bronson, S. K. (2006). Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes, 55(9), 2401-2411.
  11. [11] Yoon, S., Kim, J., & Park, S. (2016). Pathophysiology and Therapeutic Mechanisms in Diabetic Retinopathy: Current Understanding and Future Prospects. Journal of Diabetes Research, 3789217.
  12. [12] Wong, T. Y., Cheung, C. M., Larsen, M., Sharma, S., Simó, R., & Diabetic Retinopathy Barometer Study Group. (2016). Diabetic retinopathy. Nature Reviews Disease Primers, 2(1), 1-17.
  13. [13] Zhang, X., Saaddine, J. B., Chou, C. F., & Cotch, M. F. (2010). Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA, 304(6), 649-656.
  14. [14] Cheung, N., Mitchell, P., & Wong, T. Y. (2010). Diabetic retinopathy. The Lancet, 376(9735), 124-136.
  15. [15] Yau, J. W., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., & Wang, J. J. (2012). Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 35(3), 556-564.
  16. [16] Bressler, N. M., Edwards, A. R., Antoszyk, A. N., Beck, R. W., Browning, D. J., Ciardella, A. P., & Ip, M. S. (2003). Retinal thickness on stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. American Journal of Ophthalmology, 135(5), 704-712.
  17. [17] Wilkinson, C. P., Ferris, F. L. 3rd, Klein, R. E., et al. (2003). Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology, 110(9), 1677-1682. doi:10.1016/s0161-6420(03)00475-5
  18. [18] Early Treatment Diabetic Retinopathy Study Research Group. (1991). Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology, 98(5 Suppl), 786-806.
  19. [19] Klein, R., Klein, B. E., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984). The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Archives of Ophthalmology, 102(4), 527-532.
  20. [20] Bresnick, G. H., Condit, R., Syrjala, S., Palta, M., Groo, A., & Korth, K. (1984). Abnormalities of the foveal avascular zone in diabetic retinopathy. Archives of Ophthalmology, 102(9), 1286-1293.
  21. [21] Aiello, L. P. (2003). Angiogenesis and diabetic retinopathy. The American Journal of Ophthalmology, 136(1), 122-135.
  22. [22] Klein, R., & Klein, B. E. (1980). Diabetic retinopathy. Annual Review of Medicine, 31(1), 219-236.
  23. [23] Photocoagulation treatment of proliferative diabetic retinopathy. (1981). Clinical trials. Archives of Ophthalmology, 99(9), 1607-1615.
  24. [24] Hee, M. R., Puliafito, C. A., Wong, C., Duker, J. S., Reichel, E., Schuman, J. S., & Fujimoto, J. G. (1995). Quantitative assessment of macular edema with optical coherence tomography. Archives of Ophthalmology, 113(8), 1019-1029.
  25. [25] Tham, Y. C., Li, X., Wong, T. Y., Quigley, H. A., Aung, T., & Cheng, C. Y. (2014). Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology, 121(11), 2081-2090.
  26. [26] Quigley, H. A., & Broman, A. T. (2006). The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology, 90(3), 262-267.
  27. [27] Weinreb, R. N., Aung, T., & Medeiros, F. A. (2014). The pathophysiology and treatment of glaucoma: a review. JAMA, 311(18), 1901-1911.
  28. [28] Heijl, A., Leske, M. C., Bengtsson, B., Hyman, L., Bengtsson, B., & Hussein, M. (2002). Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology, 120(10), 1268-1279.
  29. [29] Foster, P. J., & Buhrmann, R. (2002). The definition and classification of glaucoma in prevalence surveys. British Journal of Ophthalmology, 86(2), 238-242.
  30. [30] Leske, M. C., Connell, A. M., Wu, S. Y., Hyman, L. G., & Schachat, A. P. (1995). Risk factors for open-angle glaucoma. The Barbados Eye Study. Archives of Ophthalmology, 113(7), 918-924.
  31. [31] Tielsch, J. M., Katz, J., Singh, K., Quigley, H. A., Gottsch, J. D., Javitt, J., & Sommer, A. (1991). A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. American Journal of Epidemiology, 134(10), 1102-1110.
  32. [32] Racette, L., Wilson, M. R., Zangwill, L. M., Weinreb, R. N., & Sample, P. A. (2003). Primary open-angle glaucoma in blacks: a review. Survey of Ophthalmology, 48(3), 295-313.
  33. [33] Varma, R., Ying-Lai, M., Francis, B. A., Nguyen, B. B., Deneen, J., Wilson, M. R., & Azen, S. P. (2004). Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology, 111(8), 1439-1448.
  34. [34] Kass, M. A., Heuer, D. K., Higginbotham, E. J., Johnson, C. A., Keltner, J. L., Miller, J. P., ... & Gordon, M. O. (2002). The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Archives of Ophthalmology, 120(6), 701-713.
  35. [35] Schuman, J. S., Hee, M. R., Puliafito, C. A., Wong, C., Pedut-Kloizman, T., Lin, C. P., ... & Fujimoto, J. G. (1995). Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography: a pilot study. Archives of Ophthalmology, 113(5), 586-596.
  36. [36] European Glaucoma Society. (2017). Terminology and guidelines for glaucoma (4th edition). Savona, Italy: PubliComm.
  37. [37] Heijl, A., Leske, M. C., Bengtsson, B., Hyman, L., Bengtsson, B., & Hussein, M. (2002). Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology, 120(10), 1268-1279.
  38. [38] Jay, J. L., & Murray, S. B. (1988). Early trabeculectomy versus conventional management in primary open angle glaucoma. British Journal of Ophthalmology, 72(12), 881-889.
  39. [39] Gedde, S. J., Schiffman, J. C., Feuer, W. J., Herndon, L. W., Brandt, J. D., Budenz, D. L., ... & Tube Versus Trabeculectomy Study Group. (2012). Treatment outcomes
  40. [40] Caprioli, J., & Varma, R. (2011). Intraocular pressure: modulation as treatment for glaucoma. American Journal of Ophthalmology, 152(3), 340-344.
  41. [41] Jonas, J. B., Budde, W. M., & Panda-Jonas, S. (1999). Ophthalmoscopic evaluation of the optic nerve head. Survey of Ophthalmology, 43(4), 293-320.
  42. [42] Leung, C. K., Cheung, C. Y., Weinreb, R. N., Qiu, Q., Liu, S., Li, H., ... & Lam, D. S. (2010). Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a prospective analysis of age- related loss. Ophthalmology, 117(4), 732-738.
  43. [43] Jonas, J. B., & Dichtl, A. (1996). Evaluation of the retinal nerve fiber layer. Survey of Ophthalmology, 40(5), 369-378.
  44. [44] Hood, D. C., & Kardon, R. H. (2007). A framework for comparing structural and functional measures of glaucomatous damage. Progress in Retinal and Eye Research, 26(6), 688-710.
  45. [45] Michaelides, M. B., et al. (2007). Diabetic retinopathy: Pathogenesis, clinical grading, management and future developments. Diabetic Medicine, 24(2), 141-150.
  46. [46] Bandello, M., et al. (2016). Diabetic retinopathy. The Lancet, 388(10050), 1455-1466.
  47. [47] Yau, L., et al. (2012). Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 35(3), 556-564.
  48. [48] Heijl, T. K., et al. (2002). Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology, 120(10), 1268-1279.
  49. [49] Johnson, C. A., Sample, P. A., Zangwill, L. M., Vasile, C., Cioffi, G. A., Liebmann, J. R., ... & Weinreb, R. N. (2006). The Early Manifest Glaucoma Trial: Overview and baseline characteristics of enrolled patients. Ophthalmology, 113(7), 1147-1153.
  50. [50] Werner, G. K., Sample, P. A., Zangwill, L. M., Vasile, C., Cioffi, G. A., Liebmann, J. R., ... & Weinreb, R. N. (2007). Frequency doubling technology perimetry for detection of visual field progression in glaucoma: A meta-analysis. Journal of Glaucoma, 16(2), 117-124.
  51. [51] Cen, L. P., Ji, J., Lin, J. W., et al. (2021). Automatic detection of 39 fundus diseases and conditions in retinal photographs using deep neural networks. Nature Communications, 12, 4828.
  52. [52] https://www.kaggle.com/datasets/gunavenkatdoddi/
  53. eye-diseases-classification